A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)
Clinical trial NCT04346108 · COMPLETED
Trial details
- NCT number
- NCT04346108
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-11
- Primary completion
- 2021-12-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.